Categories: AppCareHardware
Tear Film Innovation’s iLux treats Meibomian Gland Dysfunction by the application of light-based heat and compression under direct visualization.
Investors 2
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.05.2018 | Series B | $8.5M | - |
| 07.11.2017 | Series A | $9M | - |
Mentions in press and media 7
| Date | Title | Description |
| 19.03.2021 | 120Water on growth tear, closes on $4.5M funding round | - |
| 23.05.2018 | Term Sheet — Wednesday, May 23 | 5 Qs WITH A DEALMAKER
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
“When I looked around, I saw a lot of women who were starting businesses,” she told Term Sheet. “I recognized that in the... |
| 22.05.2018 |
Tear Film Innovations Finds $8.5M
| San Diego-based Tear Film Innovations, a developer of medical devices to help clear blocked tear glands, has raised $8.5M in a Series B funding. The funding was led by Visionary Ventures Fund and Bluestem Capital. Tear Film Innovations is l... |
| 22.05.2018 | Tear Film Innovations Closes $8.5M Series B Funding | Tear Film Innovations, Inc., a Carlsbad CA-based manufacturer of a device for the treatment of evaporative dry eye and related syndromes, completed an $8.5m Series B funding.
The round was led by Visionary Ventures Fund, L.P. and Bluestem C... |
| 08.11.2017 | Term Sheet — Wednesday, November 8 | 5 Qs WITH A DEALMAKER
Snap revealed some worse-than-expected earnings in the third quarter and a $40 million Spectacles flop during its earnings call on Tuesday. CEO Evan Spiegel noted that the company will redesign the app “to make it easi... |
| 07.11.2017 |
Tear Film Innovations Raises $9M
| San Diego-based Tear Film Innovations, a developer of a medical device for treating "dry eye", has raised $9M in a Series A funding, the company said this morning. The funding round was led by Visionary Ventures Fund and Tigris Ve... |
| 07.11.2017 | Tear Film Innovations Closes $9M Series A Funding | Tear Film Innovations, Inc., a San Diego, CA-based early-stage company developing products for the treatment of evaporative dry eye and related syndromes including Meibomian Gland Dysfunction (MGD) and blepharitis, completed a $9m Series A ... |
Reviews 0
